Results 21 to 30 of about 35,468 (143)
Understanding How Adolescents Think about the HPV Vaccine
Vaccines, 2020 Despite educational efforts, Tennessee human papillomavirus (HPV) vaccination rates are 43%, among the lowest in the United States. This study examined how adolescents think about the HPV vaccine to identify patterns and misconceptions to enhance ...
Robyn A. Pennella +2 more
doaj +1 more source
SAGE Open, 2023 Despite strenuous efforts to increase vaccination rates against human papillomavirus (HPV), the rate of vaccination remains low in the U.S. The COVID-19 pandemic poses an additional challenge to HPV vaccination.
ShinHi Han +4 more
doaj +1 more source
Vaccine: X, 2023 Objective: To examine the knowledge of cervical cancer risk factors and human papilloma virus (HPV) vaccine among Saudi women of childbearing age. Methods: An anonymous, survey-based, cross-sectional study was conducted from November 2022 to March 2023 ...
Abdulrahim Gari +8 more
doaj +1 more source
Prophylactic HPV vaccines [PDF]
Journal of Clinical Pathology, 2007 The HPV L1 VLP vaccines are immensely important developments in public health and the benefits that they promise are immense, offering the opportunity to prevent, in the long term, 80% of cervical cancers, 60% of vulval cancers and 80% of anal cancers in women. In the short to medium term they will prevent at least 90% of genital warts and have a major
openaire +3 more sources
JMIR Public Health and Surveillance, 2022 BackgroundThe human papillomavirus (HPV) vaccine is recommended for adolescents and young adults to prevent HPV-related cancers and genital warts.
Akshaya Srikanth Bhagavathula +1 more
doaj +1 more source
HPV Vaccine Hesitancy Among Medical Students in China: A Multicenter Survey
Frontiers in Public Health, 2022 Human papillomavirus (HPV) is the most common genital tract virus infection and can cause genital warts and cervical cancer. This multicenter study examined HPV information sources, vaccine hesitancy, and the association between the two variables.
Liangru Zhou +5 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 The delivery of strong HPV vaccine recommendations hinges on the expertise of healthcare providers (HCPs) in assessing patients' status and recommending HPV vaccination. We conducted a population-based cross-sectional study of HCPs practicing in Texas to examine the relationship between HPV vaccination training of HCPs and HPV vaccination status ...
Ikponmwosa Osaghae +7 more
openaire +4 more sources
HPV vaccine development after more than ten years approval
Majalah Obstetri dan Ginekologi, 2020 At present, ten years have passed since the human papillomavirus (HPV) vaccine was first approved for use in humans. Research related to HPV vaccine, both in terms of effectiveness and immugenicity in its development, has been widely carried out, such as
Brahmana Askandar
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 Vaccine confidence reflects social, individual, and political factors indicating confidence in vaccines and associated health systems. In Japan, the government ceased proactive recommendation of the human papillomavirus (HPV) vaccine in June 2013, only ...
Michiko Shuto +8 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2019 Background: Achieving optimal human papillomavirus (HPV) vaccine uptake can be delayed by parents’ HPV vaccine hesitancy, which is as a multi-stage intention process rather than a dichotomous (vaccinated/not vaccinated) outcome.
Ovidiu Tatar +4 more
doaj +1 more source